COVID-19 has caused significant morbidity and mortality around the world. However, it has been noticed that case-fatality rates have been significantly higher in Europe and North America compared to the Asia, Middle East and Africa. This could be due to several factors which include average age of the population, testing and tracing facilities, social distancing measures and difference in immunogenic response to SARS-COV-2. In this report, we have discussed the factors which may affect a population to develop herd immunity against COVID-19. We have hypothesized here that frequent prior exposure to other coronaviruses in Asian population might impart partial immunity to COVID-19. This may be the reason for significant lower number of case fatalities seen in this region compared to the west. We, therefore, propose molecular immunological studies to correlate prior exposure to coronaviruses with disease severity. This will help us to develop therapeutic targets to treat severe infection with COVID-19.
Citation: Ahmed Yaqinuddin, Ayesha Rahman Ambia, Tasnim Atef Elgazzar. Case fatalities due to COVID-19: Why there is a difference between the East and West?[J]. AIMS Allergy and Immunology, 2021, 5(1): 56-63. doi: 10.3934/Allergy.2021005
[1] | Huiting He, Mohamed Ousbika, Zakaria El Allali, Jiabin Zuo . Non-trivial solutions for a partial discrete Dirichlet nonlinear problem with p-Laplacian. Communications in Analysis and Mechanics, 2023, 15(4): 598-610. doi: 10.3934/cam.2023030 |
[2] | Dan Li, Yuhua Long . On periodic solutions of second-order partial difference equations involving p-Laplacian. Communications in Analysis and Mechanics, 2025, 17(1): 128-144. doi: 10.3934/cam.2025006 |
[3] | Zhen Wang, Luhan Sun . The Allen-Cahn equation with a time Caputo-Hadamard derivative: Mathematical and Numerical Analysis. Communications in Analysis and Mechanics, 2023, 15(4): 611-637. doi: 10.3934/cam.2023031 |
[4] | Leandro Tavares . Solutions for a class of problems driven by an anisotropic (p,q)-Laplacian type operator. Communications in Analysis and Mechanics, 2023, 15(3): 533-550. doi: 10.3934/cam.2023026 |
[5] | Tianfang Wang, Wen Zhang . Existence and concentration of homoclinic orbits for first order Hamiltonian systems. Communications in Analysis and Mechanics, 2024, 16(1): 121-146. doi: 10.3934/cam.2024006 |
[6] | Xiulan Wu, Yaxin Zhao, Xiaoxin Yang . On a singular parabolic p-Laplacian equation with logarithmic nonlinearity. Communications in Analysis and Mechanics, 2024, 16(3): 528-553. doi: 10.3934/cam.2024025 |
[7] | Wang Xiao, Xuehua Yang, Ziyi Zhou . Pointwise-in-time α-robust error estimate of the ADI difference scheme for three-dimensional fractional subdiffusion equations with variable coefficients. Communications in Analysis and Mechanics, 2024, 16(1): 53-70. doi: 10.3934/cam.2024003 |
[8] | Katica R. (Stevanović) Hedrih, Gradimir V. Milovanović . Elements of mathematical phenomenology and analogies of electrical and mechanical oscillators of the fractional type with finite number of degrees of freedom of oscillations: linear and nonlinear modes. Communications in Analysis and Mechanics, 2024, 16(4): 738-785. doi: 10.3934/cam.2024033 |
[9] | Caojie Li, Haixiang Zhang, Xuehua Yang . A new α-robust nonlinear numerical algorithm for the time fractional nonlinear KdV equation. Communications in Analysis and Mechanics, 2024, 16(1): 147-168. doi: 10.3934/cam.2024007 |
[10] | Mohamed Karim Hamdani, Lamine Mbarki, Mostafa Allaoui . A new class of multiple nonlocal problems with two parameters and variable-order fractional p(⋅)-Laplacian. Communications in Analysis and Mechanics, 2023, 15(3): 551-574. doi: 10.3934/cam.2023027 |
COVID-19 has caused significant morbidity and mortality around the world. However, it has been noticed that case-fatality rates have been significantly higher in Europe and North America compared to the Asia, Middle East and Africa. This could be due to several factors which include average age of the population, testing and tracing facilities, social distancing measures and difference in immunogenic response to SARS-COV-2. In this report, we have discussed the factors which may affect a population to develop herd immunity against COVID-19. We have hypothesized here that frequent prior exposure to other coronaviruses in Asian population might impart partial immunity to COVID-19. This may be the reason for significant lower number of case fatalities seen in this region compared to the west. We, therefore, propose molecular immunological studies to correlate prior exposure to coronaviruses with disease severity. This will help us to develop therapeutic targets to treat severe infection with COVID-19.
In this article, we study the existence of infinitely many homoclinic solutions of the following fractional discrete p-Laplacian equations:
(−Δ1)spu(a)+V(a)|u(a)|p−2u(a)=λf(a,u(a)),in Z, | (1.1) |
where s∈(0,1) and p∈(1,∞) are fixed constants, V(a)∈R+, λ is a positive parameter, f(a,⋅) is a continuous function for all a∈Z and (−Δ1)sp is the fractional discrete p-Laplacian given by
(−Δ1)spu(a)=2∑b∈Z,b≠a|u(a)−u(b)|p−2(u(a)−u(b))Ks,p(a−b),in Z, |
where the discrete kernel Ks,p has the following property: There exist two constants 0<cs,p≤Cs,p, such that
{cs,p|d|1+ps≤Ks,p(d)≤Cs,p|d|1+ps,for alld∈Z∖{0};Ks,p(0)=0. | (1.2) |
The fractional operator has received more attention recent decades because of its many applications in the real world. Many scholars have paid attention to this kind of problem, and have produced a lot of classical works, see for example [1,2,3]. As a classical fractional operator, the fractional Laplacian has wide applications in various fields such as optimization, population dynamics and so on. The fractional Laplacian on R can be defined for 0<s<1 and ν∈C∞0(RN) as
(−Δ)sν(x)=CN,sP.V.∫RNν(x)−ν(y)|x−y|N+2sdy,x∈RN, |
where CN,s is a positive constant and P.V. denotes the Cauchy principle value. In various cases involving differential equations, the Laplace operator is replaced by either the fractional Laplace operator or other more general operators, and hence the existence results have been obtained by employing variational approaches, see for instance [4,5,6,7]. These alternative approaches have been found to offer improved descriptions of numerous phenomena observed in the natural world. Correspondingly, it is necessary to give some qualitative results by employing numerical analysis. The nonlocal feature of the fractional Laplacian is one of the important aspects to be considered in numerical methods, which makes it necessary to study the existence of solutions.
Let ZH denote a grid of fixed size H>0 on R, i.e., ZH={Ha|a∈Z}. In [8], the definition of the fractional discrete Laplacian on ZH is given by
(−ΔH)sν(a)=∑b∈Z,b≠a(ν(a)−ν(b))KHs(a−b), |
where s∈(0,1), ν∈ℓs={ν:ZH→R|∑ω∈Z|ν(ω)|(1+|ω|)1+2s<∞} and
KHs(a)={4sΓ(1/2+s)√π|Γ(−s)|⋅Γ(|a|−s)H2sΓ(|a|+1+s),a∈Z∖{0},0,a=0. |
The above discrete kernel KHs has the following property: There exist two constants 0<cs≤Cs, such that for all a∈Z∖{0} there holds
csH2s|a|1+2s≤KHs(a)≤CsH2s|a|1+2s. |
In [8], Ciaurri et al. also proved that if ν is bounded then lims→1−(−ΔH)sν(a)=−ΔHν(a), where ΔH is there discrete Laplacian on ZH, i.e.
ΔHν(a)=1H2(ν(a+1)−2ν(a)+ν(a−1)). |
Moreover, under some suitable conditions and H→0, the fractional Laplacian can be approximated by the fractional discrete Laplacian.
Subsequently, let us give some existence results on the fractional difference equations. Xiang et al. [9] first investigated the fractional discrete Laplacian equations based on variational methods:
{(−Δ1)sν(a)+V(a)ν(a)=λf(a,ν(a)),fora∈Z,ν(a)→0,as|a|→∞, | (1.3) |
where f(a,⋅) is a continuous function for all a∈Z, λ>0, V(a)∈R+ and
(−Δ1)sν(a)=2∑b∈Z,b≠a(ν(a)−ν(b))Ks(a−b),in Z. |
Using the mountain pass theorem and Ekeland's variational principle under some suitable conditions, they obtained two homoclinic solutions for problem (1.3). It is evident that when p=2, the discrete fractional p-Laplace operator corresponds to the discrete fractional Laplace operator. After that, Ju et al. [10] studied the following fractional discrete p-Laplacian equations
{(−Δ1)spν(d)+V(d)|ν(d)|p−2ν(d)=λa(d)|ν(d)|q−2ν(d)+b(d)|ν(d)|r−2ν(d),ford∈Z,ν(d)→0,as|d|→∞, | (1.4) |
where a∈ℓpp−q, b∈ℓ∞, 1<q<p<r<∞, λ>0, V(a)∈R+, (−Δ1)sp is the fractional discrete p-Laplacian. Under certain conditions, they employed the Nehari manifold method to achieve the existence of at least two homoclinic solutions for problem (1.4). In [11], Ju et al. investigated the existence of multiple solutions for the fractional discrete p-Laplacian equations with various nonlinear terms via different Clark's theorems. In a recent study conducted by Ju et al. in [12], it was demonstrated that using the fountain theorem and the dual fountain theorem under the same hypotheses, two separate sequences of homoclinic solutions were derived for the fractional discrete Kirchhoff-Schrödinger equations. Based on the findings from [8], it could be deduced that Eq.(1.3) can be reformulated as the renowned discrete version of the Schrödinger equation
−Δμ(ξ)+V(ξ)μ(ξ)=λf(ξ,μ(ξ)),in Z. | (1.5) |
It is worth mentioning that in [13], Agarwal et al. first employed the variational methods to analyze Eq.(1.5). Here, We give some literature on the study of difference equations using the critical point theory, see [14,15,16].
In particular, we observe that both the nonlinear terms in [11,12] have the following symmetry condition:
(S) f(a,ν) is odd in ν.
Therefore, in this paper, we consider the nonlinear term without condition (S), and study the existence of multiple homoclinic solutions of problem (1.1). For this, let us first recall if the solution ν of Eq.(1.1) satisfies ν(d)→0 as |d|→∞, then ν is called a homoclinic solution. Suppose that V(a) and f(a,u(a)) in problem (1.1) satisfy the following assumptions:
(V) V∈ℓ1 and there is a constant V0∈(0,infa∈ZV(a)]; (ℓ1 is defined in next section)
(F) |f(a,u)|≤C(|u|p−1+|u|t−1) for any a∈Z and u∈R, where p<t<∞ and C>0 is a constant.
Set
A:=lim infτ→0+max|ζ|≤τ∑a∈ZF(a,ζ(a))τp,B:=lim supτ→0+∑a∈ZF(a,τ(a))τp,θ:=CsV0Cb‖V‖1, |
where F(a,u)=∫u0f(a,η)dη and Cs, Cb will appear in next section. Here we give the main conclusion of our paper as follows.
Theorem 1.1. Suppose that (V) and (F) are satisfied. Furthermore, the following inequality holds: A<θB. Then, for every λ∈(Cb‖V‖1pB,CsV0pA), problem (1.1) possesses infinitely many nontrivial homoclinic solutions. In addition, their critical values and their ℓ∞-norms tend to zero.
The rest of this article is arranged as follows: In Section 2, we introduce some definitions and give some preliminary results. In Section 3, we give the proof of Theorem 1.1. In Section 4, we give an example to demonstrate the main result.
Here we illustrate some notations used in this paper:
● C, Cs,ω, Cs, Cb and C∞ are diverse positive constants.
● ↪ denotes the embedding.
● → denotes the strong convergence.
First we give some basic definitions.
Let 1≤ω≤∞, we give the definition of the space (ℓω,‖⋅‖ω) as follows:
ℓω:={{μ:Z→R|∑a∈Z|μ(a)|ω<∞},if1≤ω<∞;{μ:Z→R|supa∈Z|μ(a)|<∞},ifω=∞; |
‖μ‖ω:={(∑a∈Z|μ(a)|ω)1/ω,if1≤ω<∞;supa∈Z|μ(a)|,ifω=∞. |
Through the corresponding conclusions in [17], we know that ℓω is a Banach space. Moreover, ℓω1↪ℓω2 and ‖μ‖ω2≤‖μ‖ω1 if 1≤ω1≤ω2≤∞.
Next, we give the variational framework and some lemmas of this paper.
The space (Q,‖⋅‖Q) is defined by
Q={σ:Z→R|∑a∈Z∑b∈Z|σ(a)−σ(b)|pKs,p(a−b)+∑d∈ZV(d)|σ(d)|p<∞}; |
‖σ‖pQ=[σ]ps,p+∑d∈ZV(d)|σ(d)|p=∑a∈Z∑b∈Z|σ(a)−σ(b)|pKs,p(a−b)+∑d∈ZV(d)|σ(d)|p. |
Lemma 2.1. (see [10, Lemma 2.1]) If ξ∈ℓω, then [ξ]s,ω≤Cs,ω‖ξ‖ω<∞.
Lemma 2.2. (see [11, Lemma 2.2]) Under the hypothesis (V), (Q,‖⋅‖Q) is a reflexive Banach space, and
‖σ‖:=(∑a∈ZV(a)|σ(a)|p)1/p. |
is an equivalent norm of Q.
Through Lemma 2.2, we obtain that there exist 0≤Cs≤Cb such that
Cs‖μ‖p≤‖μ‖pQ≤Cb‖μ‖p. | (2.1) |
Lemma 2.3. Under the hypothesis (V), Q↪ℓr is continuous for all p≤r≤∞.
Proof. Using the above conclusions and (V), we can deduce that
‖σ‖r≤‖σ‖p=(∑a∈Z|σ(a)|p)1p≤V−1p0(∑a∈ZV(a)|σ(a)|p)1p,∀σ∈Q. |
As desired.
Lemma 2.4. (see [10, Lemma 2.4]) If W⊂Q is a compact subset, then for ∀ι>0, ∃a0∈N such that
[∑|a|>a0V(a)|ξ(a)|p]1/p<ι,for eachξ∈W. |
For all u∈Q, we define
K(u)=D(u)−λE(u) |
where
D(u)=1p∑a∈Z∑b∈Z|u(a)−u(b)|pKs,p(a−b)+1p∑d∈ZV(d)|u(d)|p=1p‖u‖pQ |
and
E(u)=∑d∈ZF(d,u(d)). |
Clearly
infQD(μ)=infQ1p‖μ‖pQ=D(0)=0. | (2.2) |
Lemma 2.5. (see [10, Lemma 2.5]) Under the hypothesis (V), then D(σ)∈C1(Q,R) with
⟨D′(σ),ξ⟩=∑a∈Z∑b∈Z|σ(a)−σ(b)|p−2(σ(a)−σ(b))(ξ(a)−ξ(b))Ks,p(a−b)+∑d∈ZV(d)|σ(d)|p−2σ(d)ξ(d), |
for all σ,ξ∈Q.
Lemma 2.6. (see [12, Lemma 2.6]) Under the hypotheses (V) and (F), then E(σ)∈C1(Q,R) with
⟨E′(σ),ξ⟩=∑d∈Zf(d,σ(d))ξ(d) |
for all σ,ξ∈Q.
Combining Lemma 2.5 and Lemma 2.6, we know that K(σ)∈C1(Q,R).
Lemma 2.7. Under the hypotheses (V) and (F), then for ∀λ>0, every critical point of K is a homoclinic solution of problem (1.1).
Proof. Assume σ be a critical point of K, we get for ∀ξ∈Q
∑a∈Z∑b∈Z|σ(a)−σ(b)|p−2(σ(a)−σ(b))(ξ(a)−ξ(b))Ks,p(a−b)+∑a∈ZV(a)|σ(a)|p−2σ(a)ξ(a)=λ∑a∈Zf(a,σ(a))ξ(a). | (2.3) |
For each a∈Z, we define ed∈Q as follows:
ed(a):={0,ifa≠d;1,ifa=d. |
Taking ξ=ed in (2.3), we have
2∑b∈Z,b≠a|u(a)−u(b)|p−2(u(a)−u(b))Ks,p(a−b)+V(a)|u(a)|p−2u(a)=λf(a,σ(a)). |
So σ is a solution of problem (1.1). Moreover, by Lemma 2.3 and σ∈Q, we know σ(a)→0 as |a|→∞. Thus, σ is a homoclinic solution of problem (1.1).
In this section, we shall use the following Thoerem 3.1 to prove our main result. In fact, this theorem is a special version of Ricceri's variational principle [18, Lemma 2.5].
Theorem 3.1. (see [19, Lemma 2.1]) Let Q be a reflexive Banach space, K(μ):=D(μ)+λE(μ) for each μ∈Q, where D,E∈C1(Q,R), D is coercive, and λ is a real positive parameter. For every γ>infQD(μ), let
η(γ):=infμ∈D−1((−∞,γ))(supν∈D−1((−∞,γ))E(ν))−E(μ)γ−D(μ), |
and
ρ:=lim infγ→(infQD(μ))+η(γ) |
If ρ<+∞, then for every λ∈(0,1ρ), the following conclusions holds only one:
(a) there exists a global minimum of D which is a local minimum of K.
(b) there exists a sequence {μm} of pairwise distinct critical points (local minima) of K, with limm→∞D(μm)=infQD(μ), which converges to a global minimum of D.
Remark 3.1. Obviously, ρ≥0. In addition, when ρ=0, we think that 1ρ=+∞.
Proof of Theorem 1.1. Let us recall
A=lim infτ→0+max|ζ|≤τ∑a∈ZF(a,ζ(a))τp,B=lim supτ→0+∑a∈ZF(a,τ(a))τp,θ=CsV0Cb‖V‖1, |
where F(a,u)=∫u0f(a,ω)dω. Fix λ∈(Cb‖V‖1pB,CsV0pA) and set K,D,E as in Section 2. By Lemma 2.2, Lemma 2.5 and Lemma 2.6, we know Q be a reflexive Banach space and D,E∈C1(Q,R). Because of
D(μ)=1p∑a∈Z∑b∈Z|μ(a)−μ(b)|pKs,p(a−b)+1p∑d∈ZV(d)|μ(d)|p=1p‖μ‖pQ→+∞ |
as ‖μ‖Q→+∞, i.e. D is coercive. Now, we show that ρ<+∞. For this purpose, let {δn} be a positive sequence such that limn→∞δn=0 and
limn→∞max|ζ|≤δn∑a∈ZF(a,ζ(a))δpn=A. |
Put
γn:=CsV0pδpn, |
for all n∈N. Clearly, limn→∞γn=0. For n>0 is big enough, by Lemma 2.2 and (2.1), we can derive that
D−1((−∞,γn))⊂{ν∈Q:|ν(d)|≤δn,d∈Z}. | (3.1) |
Since D(0)=E(0)=0, for each n large enough, by (3.1), we get
η(γn)=infμ∈D−1((−∞,γn))(supν∈D−1((−∞,γn))∑a∈ZF(a,ν(a)))−E(μ)γn−D(μ)≤(supν∈D−1((−∞,γn))∑a∈ZF(a,ν(a)))−E(0)γn−D(0)=supν∈D−1((−∞,γn))∑a∈ZF(a,ν(a))γn≤max|w|≤δn∑a∈ZF(a,w(a))γn=pmax|w|≤δn∑a∈ZF(a,w(a))CsV0δpn. |
Therefore, by (2.2), we acquire that
ρ=lim infγ→(infQD(μ))+η(γ)=lim infγn→0+η(γn)≤limn→∞η(γn)≤limn→∞pmax|w|≤δn∑a∈ZF(a,w(a))CsV0δpn=pACsV0. | (3.2) |
From (3.2), we get
λ∈(Cb‖V‖1pB,CsV0pA)⊂(0,1ρ). |
Next, we verify that 0 is not a local minimum of K. First, suppose that B=+∞. Choosing M such that M>Cb‖V‖1pλ and let {hn} be a sequence of positive numbers, with limn→∞hn=0, there exists n1∈N such that for all n≥n1
∑a∈ZF(a,hn)>Mhpn. | (3.3) |
Therefore, let {ln} be a sequence in Q defined by
ln(a):=hn,for alla∈Z. |
It is easy to infer that ‖ln(a)‖Q→0 as n→∞. By (V), (2.1) and (3.3), we obtain
K(ln)=D(ln)−λE(ln)=1p‖ln‖pQ−λ∑a∈ZF(a,ln)=1p‖ln‖pQ−λ∑a∈ZF(a,hn)≤Cbp‖ln‖p−λ∑a∈ZF(a,hn)=Cbp∑a∈ZV(a)|ln(a)|p−λ∑a∈ZF(a,hn)=Cbp(∑a∈ZV(a))|hn|p−λ∑a∈ZF(a,hn)<Cbp‖V‖1hpn−λMhpn=(Cbp‖V‖1−λM)hpn. |
So, K(ln)<0=K(0) for each n≥n1 big enough. Next, suppose that B<+∞. Since λ>Cb‖V‖1pB, there exists ε>0 such that ε<B−Cb‖V‖1pλ. Hence, also choosing {hn} be a sequence of positive numbers, with limn→∞hn=0, there is n2∈N such that for all n≥n2
∑a∈ZF(a,hn)>(B−ε)hpn. | (3.4) |
Arguing as before and by choosing {ln} in Q as above, we get
K(ln)=D(ln)−λE(ln)=1p‖ln‖pQ−λ∑a∈ZF(a,ln)=1p‖ln‖pQ−λ∑a∈ZF(a,hn)≤Cbp‖ln‖p−λ∑a∈ZF(a,hn)=Cbp∑a∈ZV(a)|ln(a)|p−λ∑a∈ZF(a,hn)=Cbp(∑a∈ZV(a))|hn|p−λ∑a∈ZF(a,hn)<Cbp‖V‖1hpn−λ(B−ε)hpn=(Cbp‖V‖1−λ(B−ε))hpn. |
So, K(ln)<0=K(0) for each n≥n2 big enough. In general, 0 is not a local minimum of K. By Theorem 3.1, (a) is not valid, then we have a sequence {μn}⊂Q of critical points of K such that
limn→∞D(μn)=limn→∞1p‖μn‖Q=infQD(μ)=0 |
and
limn→∞K(μn)=infQD(μ)=0. |
By Lemma 2.3, we gain
‖μn‖∞≤C∞‖μn‖Q→0 |
as n→∞. By Lemma 2.7, the problem (1.1) admits infinitely many nontrivial homoclinic solutions. In addition, their critical values and their ℓ∞-norms tend to zero. This completes the proof.
Here, we give an example of a nonlinear term which can apply Theorem 1.1.
Example 4.1. We define
Ψ(n):=1333n,forn∈N+; |
Φ(n):=1333n−1,forn∈N+; |
χ(n):=13(p+1)33n−3,forn∈N+. |
Obviously, we know that Φ(n+1)<Ψ(n)<Φ(n) for all n∈N+ and limn→∞Ψ(n)=limn→∞Φ(n)=0. Set
f(a,u)=0,∀a∈Z∖N+. |
And for each a∈N+, let f(a,⋅) is a nonnegative continuous function such that
f(a,u)=0,∀u∈R∖(Ψ(a),Φ(a))and∫Φ(a)Ψ(a)f(a,η)dη=χ(a). |
There are many nonlinear terms that satisfy the above conditions. Here we give one of them as an example.
f(a,u)=∑n∈N+χ(n)2((u+Φ(n)+Ψ(n)2)2Φ2(n)−Ψ2(n))e{n}×[Ψ(n),Φ(n)](a,u) |
where eM×N is the indicator function on M×N. Then
A=lim infτ→0+max|ζ|≤τ∑a∈ZF(a,ζ(a))τp≤limn→∞max|ζ|≤Ψ(n)∑a∈ZF(a,ζ(a))Ψp(n)=limn→∞∑∞a=n+1F(a,ζ(a))Ψp(n)=limn→∞∑∞a=n+1χ(a)Ψp(n)≤limn→∞3χ(n+1)Ψp(n)=0 |
and
B=lim supτ→0+∑a∈ZF(a,ζ(a))τp≥limn→∞∑a∈ZF(a,ζ(a))Φp(n)≥limn→∞F(n,ζ(n))Φp(n)≥limn→∞χ(n)Φp(n)=+∞. |
Now it is easy to see that all the assumptions of Theorem 1.1 are satisfied, hence the corresponding conclusion can be delivered by Theorem 1.1.
B. Zhang was supported by the National Natural Science Foundation of China (No. 12171152), the Shandong Provincial Natural Science Foundation, PR China (No. ZR2023MA090) and the Cultivation Project of Young and Innovative Talents in Universities of Shandong Province.
The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.
[1] |
Delamater PL, Street EJ, Leslie TF, et al. (2019) Complexity of the basic reproduction number (R0). Emerg Infect Dis 25: 1-4. doi: 10.3201/eid2501.171901
![]() |
[2] |
Randolph HE, Barreiro LB (2020) Herd immunity: understanding COVID-19. Immunity 52: 737-741. doi: 10.1016/j.immuni.2020.04.012
![]() |
[3] |
Sarmadi M, Marufi N, Moghaddam VK (2020) Association of COVID-19 global distribution and environmental and demographic factors: An updated three-month study. Environ Res 188: 109748. doi: 10.1016/j.envres.2020.109748
![]() |
[4] |
Jin Y, Yang H, Ji W, et al. (2020) Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 12: 372. doi: 10.3390/v12040372
![]() |
[5] |
Tu H, Tu S, Gao S, et al. (2020) Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect 81: 1-9. doi: 10.1016/j.jinf.2020.04.011
![]() |
[6] |
Shi Y, Wang G, Cai XP, et al. (2020) An overview of COVID-19. J Zhejiang Univ Sci B 21: 343-360. doi: 10.1631/jzus.B2000083
![]() |
[7] |
Algaissi AA, Alharbi NK, Hassanain M, et al. (2020) Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience. J Infect Public Health 13: 834-838. doi: 10.1016/j.jiph.2020.04.016
![]() |
[8] |
COVID CDC, Team R (2020) Geographic differences in COVID-19 cases, deaths, and incidence—United States, February 12–April 7, 2020. MMWR Morb Mortal Wkly Rep 69: 465-471. doi: 10.15585/mmwr.mm6915e4
![]() |
[9] |
Dhama K, Khan S, Tiwari R, et al. (2020) Coronavirus disease 2019-COVID-19. Clin Microbiol Rev 33: e00028-20. doi: 10.1128/CMR.00028-20
![]() |
[10] |
Amariles P, Granados J, Ceballos M, et al. (2021) COVID-19 in Colombia endpoints. Are we different, like Europe? Res Social Adm Pharm 17: 2036-2039. doi: 10.1016/j.sapharm.2020.03.013
![]() |
[11] | Shokoohi M, Osooli M, Stranges S (2020) COVID-19 pandemic: What can the West learn from the East? Int J Health Policy Manag 9: 436. |
[12] |
Coccia M (2020) Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID. Sci Total Environ 729: 138474. doi: 10.1016/j.scitotenv.2020.138474
![]() |
[13] |
Chersich MF, Gray G, Fairlie L, et al. (2020) COVID-19 in Africa: care and protection for frontline healthcare workers. Glob Health 16: 46. doi: 10.1186/s12992-020-00574-3
![]() |
[14] |
Rosenthal PJ, Breman JG, Djimde AA, et al. (2020) COVID-19: Shining the light on Africa. Am J Trop Med Hyg 102: 1145-1148. doi: 10.4269/ajtmh.20-0380
![]() |
[15] |
Alwahaibi N, Al-Maskari M, Al-Dhahli B, et al. (2020) A review of the prevalence of COVID-19 in the Arab world. J Infect Dev Ctries 14: 1238-1245. doi: 10.3855/jidc.13270
![]() |
[16] |
Khanna RC, Cicinelli MV, Gilbert SS, et al. (2020) COVID-19 pandemic: Lessons learned and future directions. Indian J Ophthalmol 68: 703-710. doi: 10.4103/ijo.IJO_843_20
![]() |
[17] |
Smith DR (2019) Herd Immunity. Vet Clin North Am Food Anim Pract 35: 593-604. doi: 10.1016/j.cvfa.2019.07.001
![]() |
[18] |
Fine P, Eames K, Heymann DL (2011) “Herd immunity”: a rough guide. Clin Infect Dis 52: 911-916. doi: 10.1093/cid/cir007
![]() |
[19] |
Meyer B, Drosten C, Muller MA (2014) Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res 194: 175-183. doi: 10.1016/j.virusres.2014.03.018
![]() |
[20] |
Hu Z, Song C, Xu C, et al. (2020) Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 63: 706-711. doi: 10.1007/s11427-020-1661-4
![]() |
[21] |
Lipsitch M, Grad YH, Sette A, et al. (2020) Cross-reactive memory T cells and herd immunity to SARS-CoV-2. Nat Rev Immunol 20: 709-713. doi: 10.1038/s41577-020-00460-4
![]() |
[22] |
Grifoni A, Weiskopf D, Ramirez SI, et al. (2020) Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181: 1489-1501. doi: 10.1016/j.cell.2020.05.015
![]() |
[23] |
Sekine T, Perez-Potti A, Rivera-Ballesteros O, et al. (2020) Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183: 158-168. doi: 10.1016/j.cell.2020.08.017
![]() |
[24] |
Shrock E, Fujimura E, Kula T, et al. (2020) Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science 370: eabd4250. doi: 10.1126/science.abd4250
![]() |
[25] |
Fontanet A, Cauchemez S (2020) COVID-19 herd immunity: where are we? Nat Rev Immunol 20: 583-584. doi: 10.1038/s41577-020-00451-5
![]() |
[26] |
Yaqinuddin A (2020) Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities. Med Hypotheses 144: 110049. doi: 10.1016/j.mehy.2020.110049
![]() |
[27] |
Britton T, Ball F, Trapman P (2020) A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2. Science 369: 846-849. doi: 10.1126/science.abc6810
![]() |
[28] | Gomes MGM, Corder RM, King JG, et al. (2020) Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold. medRxiv In press. |
1. | Meiqiang Feng, Nontrivial p-convex solutions to singular p-Monge-Ampère problems: Existence, Multiplicity and Nonexistence, 2024, 16, 2836-3310, 71, 10.3934/cam.2024004 | |
2. | Caihong Gu, Yanbin Tang, Well-posedness of Cauchy problem of fractional drift diffusion system in non-critical spaces with power-law nonlinearity, 2024, 13, 2191-950X, 10.1515/anona-2024-0023 | |
3. | Eleonora Amoroso, Angela Sciammetta, Patrick Winkert, Anisotropic (→p,→q)-Laplacian problems with superlinear nonlinearities, 2024, 16, 2836-3310, 1, 10.3934/cam.2024001 |